Serenus Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$404K Hold
439
0.08% 45
2025
Q4
$472K Buy
439
+10
+2% +$9.56K 0.09% 41
2025
Q3
$327K Sell
429
-55
-11% -$40.9K 0.06% 51
2025
Q2
$377K Sell
484
-25
-5% -$19.4K 0.06% 45
2025
Q1
$420K Buy
509
+80
+19% +$66.6K 0.07% 39
2024
Q4
$331K Buy
+429
New +$355K 0.06% 39

Other funds holding LLY

Serenus Wealth Advisors's LLY Position: Q1 2026 in Review

Serenus Wealth Advisors held its Eli Lilly (LLY) position steady in Q1 2026 at 439 shares worth $404K. The position accounts for 0.08% of the portfolio, ranked #45.

Serenus Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $472K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Serenus Wealth Advisors held 439 shares of Eli Lilly worth $404K as of Q1 2026.
  • Serenus Wealth Advisors left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.08% of Serenus Wealth Advisors's portfolio in Q1 2026, its #45 holding.
  • Serenus Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Serenus Wealth Advisors's Eli Lilly position peaked at $472K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Serenus Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.